TABLE 1

Demographic Data of TAO Patients Undergoing 99mTc-P829 Scintigraphy (n = 44)

Patient IDDD (mo)NOSPECSSNIodSNIosCASodCASosVUodVUosPretreatment*OM*TF
006824.25.585.5000111
007534.24.925.3966++++1, 2, 4, 5, 662
00832.154+++112
0101034.25.235.4611111
012214.26.435.9742+1, 2, 51, 62
01554.37.057.0143++1, 2, 311
027234.26.045.1577++++++1, 212
030263.15.004.8867++++113
0182024.25.546.4922+3104
02214.26.826.0477++++++1, 222
021744.25.976.0855++111
035674.24.925.4664+++1, 2, 3, 5, 7103
03250.05.235.2311113
031264.16.206.0022++1, 212
03754.15.735.1964+++123
038223.24.845.0822++1, 511
03942.15.395.4611001
04310.011+1, 812
04444.16.016.1665+++++112
046303.15.115.9742+1, 2, 501
047374.15.706.2811+++1, 221
049102.022112
05031.000111
051254.26.246.4723+++1, 2, 561
052544.35.865.3546+++++1, 2, 5, 1161
05344.16.016.4311111
0543604.26.085.5475+++++1, 421
058172.011121
062164.26.045.8966++++++1, 2, 911
066484.24.264.3877++++1, 2, 3, 9102
068404.25.425.5875+++1, 212
070104.175+++1, 212
07284.26.406.6075+++112
07522.010112
076f42.05.395.70211, 101, 101
079104.25.355.5475++++++113
08152.021+1, 5, 10101
077224.25.815.9711++1, 2, 5104
064254.25.395.3533++1, 2, 5, 109, 102
08543.064++++112
086364.25.355.58111, 2, 5, 8, 1181
089104.145++++112
072124.26.436.7465++2, 5, 102, 102
092543.043++112
  • * Pretreatment and ongoing medication: 1 = carbimazole; 2 = steroids; 3 = irradiation; 4 = radioiodine; 5 = thyroid resection; 6 = apheresis; 7 = octreotide; 8 = photopheresis; 9 = β-blocking agents; 10 = thyroxin; 11 = orbital decompression according to Olivari (39).

  • Thyroid function: 1 = euthyroid; 2 = hyperthyroid; 3 = latent hyperthyroid; 4 = latent hypothyroid.

  • ID = identification; DD = disease duration; SNI = superonasal index; od = oculus dexter (right eye); os = oculus sinister (left eye); VU = visual uptake; OM = ongoing medication; TF = thyroid function.